{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:55:32Z","timestamp":1790582132818,"version":"4.1.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Reprod. Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Preterm premature rupture of membranes (PPROM) is a high-risk obstetric complication. Ascending infection and histological chorioamnionitis (HCA) frequently occur after membrane rupture, contributing to severe adverse maternal and fetal outcomes. Early prediction of HCA using non-invasive biomarkers allows timely clinical management, while the predictive efficacy of C-reactive protein (CRP) for subsequent HCA in PPROM patients remains inconsistent across existing studies. This meta-analysis aimed to systematically evaluate the predictive association.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched PubMed, Scopus, Web of Science and the Cochrane Library from inception to May 20, 2026 for studies on serum CRP and subsequent HCA in PPROM patients. Pooled mean differences (MD) of admission CRP concentrations were calculated using random-effects meta-analysis with results visualized via forest plots. Leave-one-out sensitivity analysis confirmed robustness. Subgroup analyses and meta-regression were applied to explore potential sources of heterogeneity. Funnel plots, combined with Egger's test and Begg's test, were used to evaluate publication bias. All statistical analyses were conducted using R software (version 4.6.0).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Initially, 11 studies were screened. After excluding one low-quality study, 10 studies (1,791 participants) were ultimately included. The pooled results demonstrated that PPROM patients who subsequently developed HCA exhibited higher admission CRP levels than non-HCA controls (MD\u2009=\u20090.439, 95% CI: 0.179\u20130.700), with substantial heterogeneity (\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200987.7%). Meta-regression and subgroup exploration suggested sample size may partially drive cross-study heterogeneity; this moderator accounted for 31.19% of total variance, with a borderline significant association (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.05). Sensitivity analysis confirmed the stability of the pooled estimates. Egger's test revealed no significant publication bias (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;gt;\u20090.05), but the substantial heterogeneity warrants caution in interpretation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This meta-analysis suggests that elevated admission CRP levels are modestly correlated with subsequent HCA in PPROM populations. CRP may serve as an auxiliary indicator to assist early risk stratification; however, its clinical utility is limited by the small effect size and substantial heterogeneity across studies. Given the observational design of the included studies, these findings represent association rather than causation. Prospective cohort studies with standardized protocols are needed to confirm these results and assess the incremental value of CRP over existing clinical predictors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:ext-link>\n                      , identifier CRD420261404654.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/frph.2026.1912720","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:03:12Z","timestamp":1790578992000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of admission C-reactive protein levels and histological chorioamnionitis in patients with preterm premature rupture of membranes: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"8","author":[{"given":"Cunling","family":"Zhang","sequence":"first","affiliation":[{"name":"Tianjin Institute of Gynecology Obstetrics, Tianjin Central Hospital of Gynecology Obstetrics","place":["Tianjin, China"]},{"name":"Tianjin Key Laboratory of Human Development and Reproductive Regulation, Tianjin Central Hospital of Obstetrics Gynecology","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Wei","sequence":"additional","affiliation":[{"name":"Tianjin Institute of Gynecology Obstetrics, Tianjin Central Hospital of Gynecology Obstetrics","place":["Tianjin, China"]},{"name":"Tianjin Key Laboratory of Human Development and Reproductive Regulation, Tianjin Central Hospital of Obstetrics Gynecology","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[{"name":"Tianjin Institute of Gynecology Obstetrics, Tianjin Central Hospital of Gynecology Obstetrics","place":["Tianjin, China"]},{"name":"Tianjin Key Laboratory of Human Development and Reproductive Regulation, Tianjin Central Hospital of Obstetrics Gynecology","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyi","family":"Xu","sequence":"additional","affiliation":[{"name":"Tianjin Institute of Gynecology Obstetrics, Tianjin Central Hospital of Gynecology Obstetrics","place":["Tianjin, China"]},{"name":"Tianjin Key Laboratory of Human Development and Reproductive Regulation, Tianjin Central Hospital of Obstetrics Gynecology","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[{"name":"Tianjin Institute of Gynecology Obstetrics, Tianjin Central Hospital of Gynecology Obstetrics","place":["Tianjin, China"]},{"name":"Tianjin Key Laboratory of Human Development and Reproductive Regulation, Tianjin Central Hospital of Obstetrics Gynecology","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"5714","DOI":"10.1038\/s41598-022-09743-3","article-title":"Incidence of preterm premature rupture of membranes and its association with inter-pregnancy interval: a prospective cohort study","volume":"12","author":"Jena","year":"2022","journal-title":"Sci Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-026-08463-7","article-title":"Latency following preterm prelabor rupture of membranes before 34 weeks of gestation and its association with perinatal outcomes: a retrospective cohort study","volume":"313","author":"L\u00f3pez-Mart\u00ednez","year":"2026","journal-title":"Arch Gynecol Obstet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e85277","DOI":"10.1371\/journal.pone.0085277","article-title":"Systemic and local inflammatory response in women with preterm prelabor rupture of membranes","volume":"9","author":"Cobo","year":"2014","journal-title":"PLoS One"},{"key":"B5","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/aogs.12905","article-title":"Gestational age is more important for short-term neonatal outcome than microbial invasion of the amniotic cavity or intra-amniotic inflammation in preterm prelabor rupture of membranes","volume":"95","author":"Rodr\u00edguez-Trujillo","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.3109\/14767058.2015.1086329","article-title":"Neonatal outcomes in subgroups of women with preterm prelabor rupture of membranes before 34 weeks","volume":"29","author":"Stepan","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7610","DOI":"10.1016\/j.vaccine.2019.05.030","article-title":"Chorioamnionitis: case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"37","author":"Kachikis","year":"2019","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1191254","DOI":"10.3389\/fmed.2023.1191254","article-title":"Clinical chorioamnionitis: where do we stand now?","volume":"10","author":"Lukanovi\u0107","year":"2023","journal-title":"Front Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/IJPM.IJPM_464_19","article-title":"Chorioamnionitis: establishing a correlation between clinical and histological diagnosis","volume":"63","author":"Aljerian","year":"2020","journal-title":"Indian J Pathol Microbiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1080\/14767058.2019.1689945","article-title":"Histological chorioamnionitis and risk of pulmonary complications in preterm births: a systematic review and meta-analysis","volume":"34","author":"Sarno","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e2531158","DOI":"10.1001\/jamanetworkopen.2025.31158","article-title":"Histologic chorioamnionitis and neurodevelopment in preterm infants","volume":"8","author":"Peterson","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B12","doi-asserted-by":"publisher","first-page":"B2","DOI":"10.1016\/j.ajog.2024.07.016","article-title":"Society for maternal-fetal medicine consult series #71: management of previable and periviable preterm prelabor rupture of membranes","volume":"231","author":"Battarbee","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jogc.2022.08.014","article-title":"Guideline no. 430: diagnosis and management of preterm prelabour rupture of membranes","volume":"44","author":"Ronzoni","year":"2022","journal-title":"J Obstet Gynaecol Can"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1564607","DOI":"10.3389\/fimmu.2025.1564607","article-title":"Redefining CRP in tissue injury and repair: more than an acute pro-inflammatory mediator","volume":"16","author":"Potempa","year":"2025","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0150217","DOI":"10.1371\/journal.pone.0150217","article-title":"Maternal serum C-reactive protein in women with preterm prelabor rupture of membranes","volume":"11","author":"Stepan","year":"2016","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e13594","DOI":"10.1111\/aji.13594","article-title":"Non-invasive prediction of histologic chorioamnionitis using maternal serum markers in women with preterm prelabour rupture of membranes","volume":"88","author":"Shi","year":"2022","journal-title":"Am J Reprod Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1186\/s12884-025-08446-7","article-title":"Systemic immune-inflammation index predicts acute histologic chorioamnionitis pathologic staging and neonatal respiratory distress syndrome in women with preterm premature rupture of membranes: a retrospective cohort study","volume":"25","author":"Chen","year":"2025","journal-title":"BMC Pregnancy Childbirth"},{"key":"B18","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/emermed-2020-209567","article-title":"Population, intervention, comparison, outcomes and study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews","volume":"37","author":"Amir-Behghadami","year":"2020","journal-title":"Emerg Med J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e82350","DOI":"10.7759\/cureus.82350","article-title":"A systematic review of inflammatory markers in polycystic ovary syndrome (PCOS) and meta-analysis of interleukin-6 (IL-6) in case-control studies","volume":"17","author":"Bansal","year":"2025","journal-title":"Cureus"},{"key":"B22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5152\/jtgga.2012.23","article-title":"Maternal plasma prolidase, matrix metalloproteinases 1 and 13, and oxidative stress levels in pregnancies complicated by preterm premature rupture of the membranes and chorioamnionitis","volume":"13","author":"Ender Soydinc","year":"2012","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"B23","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1471-0528.2007.01385.x","article-title":"Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review","volume":"114","author":"Trochez-Martinez","year":"2007","journal-title":"BJOG"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408363.2026.2665297","article-title":"Blood biomarkers for the diagnosis of chorioamnionitis following preterm premature rupture of membranes: a systematic review and meta-analysis of studies since 2020","author":"Puravet","year":"2026","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13643-020-01389-4","article-title":"Maternal inflammatory markers for chorioamnionitis in preterm prelabour rupture of membranes: a systematic review and meta-analysis of diagnostic test accuracy studies","volume":"9","author":"Etyang","year":"2020","journal-title":"Syst Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejogrb.2018.05.043","article-title":"Validation of diagnostic tests for histologic chorioamnionitis: systematic review and meta-analysis","volume":"228","author":"Cata\u00f1o Sabogal","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"17534259241306237","DOI":"10.1177\/17534259241306237","article-title":"Plasma acute phase proteins as potential predictors of intra-amniotic inflammation and infection in preterm premature rupture of membranes","author":"Cho","year":"2024","journal-title":"Innate Immun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"668","DOI":"10.5152\/balkanmedj.2016.160293","article-title":"Diagnostic and prognostic value of presepsin for subclinical chorioamnionitis in pregnancies between 23 and 28 week with preterm premature rupture of the membranes","volume":"33","author":"Cakar","year":"2016","journal-title":"Balkan Med J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/aji.12323","article-title":"Changes in maternal blood inflammatory markers as a predictor of chorioamnionitis: a prospective multicenter study","volume":"73","author":"Le Ray","year":"2015","journal-title":"Am J Reprod Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0283974","DOI":"10.1371\/journal.pone.0283974","article-title":"Clinical characteristics, complications, and predictive model of histological chorioamnionitis in women with preterm premature rupture of membranes","volume":"18","author":"Galletta","year":"2023","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0173382","DOI":"10.1371\/journal.pone.0173382","article-title":"The delta neutrophil index as a predictive marker of histological chorioamnionitis in patients with preterm premature rupture of membranes: a retrospective study","volume":"12","author":"Cho","year":"2017","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.tjog.2022.11.006","article-title":"Predicting chorioamnionitis in patients with preterm premature rupture of membranes using inflammatory indexes: a retrospective study","volume":"62","author":"Kong","year":"2023","journal-title":"Taiwan J Obstet Gynecol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"390","DOI":"10.12659\/MSM.891203","article-title":"Related factors and adverse neonatal outcomes in women with preterm premature rupture of membranes complicated by histologic chorioamnionitis","volume":"21","author":"Xie","year":"2015","journal-title":"Med Sci Monit"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-026-08896-7","article-title":"Evaluation on the significance of miR-199a-5p for preterm premature rupture of membranes with chorioamnionitis","volume":"26","author":"Hu","year":"2026","journal-title":"BMC Pregnancy Childbirth"},{"key":"B35","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1089\/jir.2012.0151","article-title":"uPAR, IL-33, and ST2 values as a predictor of subclinical chorioamnionitis in preterm premature rupture of membranes","volume":"33","author":"\u00c7ekmez","year":"2013","journal-title":"J Interferon Cytokine Res"}],"container-title":["Frontiers in Reproductive Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2026.1912720\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:03:12Z","timestamp":1790578992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2026.1912720\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":35,"alternative-id":["10.3389\/frph.2026.1912720"],"URL":"https:\/\/doi.org\/10.3389\/frph.2026.1912720","relation":{},"ISSN":["2673-3153"],"issn-type":[{"value":"2673-3153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"1912720"}}